Author

Gajanan Panchal

Observed name: Gajanan Vithoba Panchal

Institution: Lupin Pharmaceuticals (India)

Observed institution: Lupin Pharmaceuticals (India)

ORCID: 0000-0002-7691-922X

Observed ORCID: 0000-0002-7691-922X

OpenAlex ID: A5089886384

Nationwide assessment of bone mineral density: A comprehensive cross-sectional bone-fit study in the Indian population

2025 · Gurunath Chavan, Kamlesh Patel, et al. · Journal of Preventive Medicine and Holistic Health · 2

A brief review on efficacy and safety of brivaracetam in the management of partial onset epilepsy

2021 · Gajanan Vithoba Panchal, Vijay Nath Mishra · IP Indian Journal of Neurosciences · 2

The Current Landscape of Nanopaclitaxel Formulations and the Benefits of Polymeric Micellar Paclitaxel in Solid Tumors

2026 · Vaibhav Choudhary, Nirmal Raut, et al. · Indian Journal of Medical and Paediatric Oncology · 1

Real-World Observational Clinical Study Assessing the Effectiveness and Safety of Vonoprazan-Based Dual Therapy Versus Proton Pump Inhibitor-Based Triple Therapy for Helicobacter pylori Eradication

2026 · Sanjay Bandyopadhyay, Gajanan Panchal, et al. · Gastroenterology Research

Role of cetuximab in recurrent and/or metastatic head and neck cancer (R/M-HNC) in the era of immunotherapy: Consensus from India

2026 · M V Chandrakanth, Rajat Bajaj, et al. · South Asian Journal of Cancer

Efficacy and safety of monthly low-dose denosumab for the prevention of skeletal-related events in patients with multiple myeloma: A real-world five-patient case series

2026 · Nitin Gupta, Gajanan Panchal, et al. · Onco Critical Care.

Cetuximab in platinum-ineligible patients with locally advanced squamous cell carcinoma of the head and neck: Consensus from India

2025 · Agarwala Vivek, Aggarwal Shyam, et al. · Indian Journal of Cancer

Micronutrient Supplementation Augments Adenosine Triphosphate (ATP) production in Caco-2 cells

2025 · Gaurav Kumar Jain, Pavitra Solanki, et al. · Journal of Drug Delivery and Therapeutics

Safety and Clinical characteristics of patients with Ovarian cancer: Rucaparib Real-world Evidence (The SCORE Study)

2025 · Gajanan Panchal, Atul Narayankar, et al. · Onco Critical Care.

Works count: 9

Citation count: 5

H-index: 2

I10-index: